NVCN - Neovasc Inc.About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $2.08 | Open | $2.10 |
| Volume | 101.6K | Market Cap | 47.11M |
| Yield | Last Dividend |
| Neovasc : Management'sDiscussion and Ana... | 08/06/20 |
| Neovasc Inc. Management's Discussion and Analysis FOR THE THREE AND SIX MONTHS ENDED JUNE 30,??? | August 6, 2020 | |
| Neovasc Announces Second Quarter Financi... | 08/06/20 |
| VANCOUVER and MINNEAPOLIS - (NewMediaWire) - August 06, 2020 - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the develop... | |
| Neovasc : Announces Second Quarter Finan... | 08/06/20 |
| News Release August 6, 2020 Neovasc Announces Second Quarter Financial Results ??? | August 6, 2020 | |
| Neovasc : Announces Closing of $11.5 Mil... | 06/16/20 |
| News Release June 16, 2020 Neovasc Announces Closing of $11.5 Million ??? | June 17, 2020 | |
| Neovasc : 5 NVC Q1 F20 MDA 200506 FINAL ... | 05/21/20 |
| Neovasc Inc. Management's Discussion and Analysis FOR THE THREE MONTHS ENDED MARCH 31, 2020 AND??? | May 21, 2020 | |
| Neovasc : 4 NVC Q1 F20 FS 200506 FINAL |... | 05/21/20 |
| Neovasc Inc. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019 ??? | May 21, 2020 | |
| Neovasc (NVCN) May Report Negative Earni... | 04/30/20 |
| Neovasc (NVCN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| The Daily Biotech Pulse: Fate Therapeuti... | 04/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2) BEL... | |
| The Daily Biotech Pulse: InflaRx Begins ... | 04/01/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) At... | |
| Neovasc (NVCN) Q4 2019 Earnings Snapshot | 03/30/20 |
| ??? Neovasc (NASDAQ: NVCN) reported a comprehensive loss of $1.45 per share for Q4 2019 vs. a loss of $5.07 per share in the prior-year quarter. ??? R... | |
| The Daily Biotech Pulse: NY State Endors... | 03/11/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10)... | |
| Neovasc (NVCN) Releases Update on Reduce... | 03/09/20 |
| Neovasc (NVCN) expects an approval from the FDA for Reducer by end of 2020. | |
| 4 Stocks To Watch For January 2, 2020 | 01/02/20 |
| Some of the stocks that may grab investor focus today are: Wall Street expects Resources Connection, Inc. (NASDAQ: RECN ) to post quarterly earnings a... | |
| Neovasc News: NVCN Stock Skyrockets 65% ... | 12/31/19 |
| Neovasc (NVCN) news for Tuesday about the company submitting a PMA to the U.S. Food and Drug Administration has NVCN stock soaring. | |
| Neovasc Higher By 160% After Submitting ... | 12/31/19 |
| Neovasc Inc. (NASDAQ: NVCN ) shares are trading sharply higher Tuesday after the company announced it had submitted a premarket approval application t... | |
| Neovasc's stock shoots higher after subm... | 12/31/19 |
| Shares of Neovasc Inc. shot up 79% in premarket trading Tuesday, after the medical device company said it submitted a premarket approval application (... | |
| Neovasc (NVCN) Reports Q3 Loss, Misses R... | 11/07/19 |
| Neovasc (NVCN) delivered earnings and revenue surprises of 23.77% and -41.18%, respectively, for the quarter ended September 2019. Do the numbers hold... | |
| Neovasc (NVCN) Expected to Beat Earnings... | 10/31/19 |
| Neovasc (NVCN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key... | |
| The Daily Biotech Pulse: European Cheer ... | 07/30/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 29) ... | |
| The Daily Biotech Pulse: Setback For Bri... | 07/25/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 24) ... | |
| The Daily Biotech Pulse: Jounce Jumps On... | 07/24/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) ... | |
| Penny Stock Neovasc Rallies On Patent Ab... | 06/11/19 |
| Shares of the Canadian medical device maker Neovasc Inc (NASDAQ: NVCN ) were rallying Tuesday following the circulation of a document with a patent ab... | |
| Neovasc up 46% premarket on positive two... | 05/23/19 |
| No summary available. | |
| Neovasc closes debt and equity offering ... | 05/17/19 |
| No summary available. | |
| Neovasc Announces Private Placement of C... | 05/14/19 |
| VANCOUVER, May 14, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN), a leader in the development of minimally invasive trans... | |
| Neovasc Inc. (NVCN) CEO Fred Colen on Q1... | 05/09/19 |
| Neovasc Inc. (NASDAQ:NVCN) Q1 2019 Earnings Conference Call May 09, 2019 4:30 PM ET Company Participants Jeremy Feffer - Investor Relations Fred Colen... | |
| Neovasc misses by $0.14, beats on revenu... | 05/09/19 |
| No summary available. | |
| Neovasc settles remaining litigation wit... | 04/17/19 |
| No summary available. | |
| The Daily Biotech Pulse: Blueprint Medic... | 03/28/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 27)... | |
| Neovasc Inc. (NVCN) CEO Fredericus Colen... | 03/21/19 |
| Neovasc Inc. (NASDAQ:NVCN) Q4 2018 Results Earnings Conference Call March 21, 2019, 04:30 PM ET Company Participants Jeremy Feffer - MD, LifeSci Advis... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
